These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A FAST lesson in stroke treatment. Taylor B Tex Dent J; 2013 Jun; 130(6):494-6. PubMed ID: 24195189 [No Abstract] [Full Text] [Related]
25. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital. Hsu YC; Sung SF; Ong CT; Wu CS; Su YH Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569 [TBL] [Abstract][Full Text] [Related]
26. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up]. Wahlgren NG Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940 [No Abstract] [Full Text] [Related]
27. Tissue plasminogen activator approved for stroke. Barber A; Gommans J N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728 [No Abstract] [Full Text] [Related]
28. A hundred (and one) graphs tell only part of the story. Silbergleit R Ann Emerg Med; 2009 Sep; 54(3):342-3. PubMed ID: 19695418 [No Abstract] [Full Text] [Related]
30. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Reid JM; Gubitz GJ; Phillips SJ Neurology; 2006 Nov; 67(9):1724-5; author reply 1724-5. PubMed ID: 17101926 [No Abstract] [Full Text] [Related]
31. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window. Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954 [TBL] [Abstract][Full Text] [Related]
32. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making]. Kakuda W; Abo M Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605 [TBL] [Abstract][Full Text] [Related]
33. Thrombolysis in patients with stroke and marked clinical fluctuations. Calleja S; Rodríguez S; Lahoz CH Arch Neurol; 2009 Mar; 66(3):416-8. PubMed ID: 19273766 [No Abstract] [Full Text] [Related]
34. Expectations for tPA is pathway to litigation. ED Manag; 2011 Feb; 23(2):18-9. PubMed ID: 21400969 [No Abstract] [Full Text] [Related]
35. Characterization of cerebral tissue by MRI map ISODATA in embolic stroke in rat. Ding G; Jiang Q; Li L; Zhang L; Zhang ZG; Soltanian-Zadeh H; Li Q; Whitton PA; Ewing JR; Chopp M Brain Res; 2006 Apr; 1084(1):202-9. PubMed ID: 16566903 [TBL] [Abstract][Full Text] [Related]
36. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing. Wang Y; Wu D; Zhao X; Ma R; Guo X; Wang C; Liu L; Zhao W; Wang Y Surg Neurol; 2009 Aug; 72 Suppl 1():S2-7. PubMed ID: 18423545 [TBL] [Abstract][Full Text] [Related]
37. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. Switzer JA; Hall C; Gross H; Waller J; Nichols FT; Wang S; Adams RJ; Hess DC J Emerg Med; 2009 Jan; 36(1):12-8. PubMed ID: 18242925 [TBL] [Abstract][Full Text] [Related]